Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Researchers Develop Effective, Single Dose Ebola Vaccine

April 9, 2015 8:41 am | by University of Texas | News | Comments

A team of researchers has developed a quick-acting vaccine that is both safe and effective with a single dose against the Ebola strain that killed thousands of people in West Africa last year. Read more...


Allergy Drug Inhibits Hepatitis C in Mice

April 9, 2015 8:41 am | by National Institute of Health | News | Comments

An over-the-counter drug indicated to treat allergy symptoms limited hepatitis C virus activity in infected mice. Read more...


Novel Antibody Therapy May Suppress HIV Infection

April 8, 2015 1:05 pm | by Stephanie Guzowski, Editor | News | Comments

In a first study to test a new generation of HIV antibodies in humans, an experimental therapy lowered the virus amount in a patient’s blood. The trial results, published in Nature, showed that a single dose of potent antibody, 3BNC117, was well tolerated and temporarily reduced viral loads. Read more...


Risk of Breast, Ovarian Cancer May Differ By Type of BRCA1, BRCA2 Mutation: Study

April 8, 2015 12:51 pm | by UPenn | News | Comments

In a study involving more than 31,000 women with cancer-causing mutations in the BRCA1 or BRCA2 genes, researchers at the Basser Center for BRCA, the Abramson Cancer Center, and the Perelman School of Medicine at the University of Pennsylvania, identified mutations that are associated with significantly different risks of breast and ovarian cancers. Read more...


Price of Cancer Drugs Varies Widely Based on Who’s Paying

April 8, 2015 12:44 pm | News | Comments

Uninsured cancer patients are paying anywhere from two to 43 times what Medicare would pay for chemotherapy drugs, according to a new study from the University of North Carolina at Chapel Hill. Read more...


Merck's Potential HCV Drug Gets Special FDA Designation

April 8, 2015 12:40 pm | by Associated Press | News | Comments

Merck & Co. said Wednesday that the Food and Drug Administration granted the pharmaceutical company's developing hepatitis C treatment two special designations. Read more...


Mylan Proposes Bid to Buy Perrigo for $28.9B

April 8, 2015 11:55 am | by Ryan Bushey, Associate Editor | News | Comments

The combination of Mylan and Perrigo could form one of the world's largest generic drug makers. Read more....


World-First Human Hendra Virus Clinical Trials Begin

April 8, 2015 8:23 am | by University of Queensland | News | Comments

An antibody manufactured at The University of Queensland will be used in world-first human Hendra virus clinical trials starting this month. Read more...


Body's Cancer Defenses Hijacked to Make Pancreatic and Lung Cancer More Aggressive

April 8, 2015 8:22 am | by Cancer Research UK | News | Comments

Scientists have discovered that a vital self-destruct switch in cells is hijacked - making some pancreatic and non small cell lung cancers more aggressive. Read more...


Mixed Picture on the Effectiveness of Viagra and Other Related Drugs

April 8, 2015 8:22 am | by University of Manchester | News | Comments

Restoring impotence using drugs such as Viagra still leaves older sufferers dissatisfied with their sex lives. Read more...


New Therapeutic Option Available for Select Treatment Resistant Lung Cancer Patients

April 8, 2015 8:22 am | News | Comments

NSCLC can be characterized based on a patient's genetic abnormalities that are causing the cancer growth and researchers have identified over 12 of these genetic abnormalities. Read more...


Mylan Launches First Generic Version of Generess Fe

April 8, 2015 8:21 am | News | Comments

Mylan has 269 ANDAs pending FDA approval representing $104.1 billion in annual brand sales. Read more...


Analyst: Top Mid-Cap Biotech Companies Increased Revenues to $26.5 Billion in 2014

April 8, 2015 8:21 am | by Adam Dion, Healthcare Industry Analyst, GlobalData | Articles | Comments

The combined total revenues for the peer group of 35 mid-cap biotech companies increased from $24.8 billion in 2013 to $26.5 billion in 2014. Read more...


Tau is the Main Culprit in Alzheimer’s, say Two Studies

April 7, 2015 5:17 pm | by Cynthia Fox, Science Writer | Articles | Comments

Two recent studies have concluded that tau, not amyloid, is the main driver behind Alzheimer’s disease (AD). Read more...


Specialty Drug Prescription Service ZappRx Raises $5.6M

April 7, 2015 2:29 pm | by Ryan Bushey, Associate Editor | Articles | Comments

This brings the total funding for the Boston-based startup to 8.8 million. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.